Cilomilast is an orally active, second-generation phosphodiesterase (PDE) inhibitor that may be effective in the treatment of asthma and chronic obstructive pulmonary disease (COPD). It has high selectivity for the cyclic AMP-specific, or PDE4, isoenzyme that predominates in pro-inflammatory and immune cells and is ten-fold more selective for PDE4D than for PDE4A, B and C.
PRODUCT PROPERTIES |
Formula: | | C20H25NO4 |
MW: | | 343.42 |
CAS: | | 153259-65-5 |
Purity: | | ≥98% by HPLC |
Appearance: | | White to off-white solid |
Solubility: | | DMSO (~15 mg/ml) |
Long Term Storage: | | -20°C |
Background / Technical Information: | | For the Original Manufacturer's data sheet please click here. |
|
|
|